Anna Raninger

Anna Raninger is a researcher affiliated with the Institute of Experimental and Clinical Cell Therapy at Paracelsus Medical University (PMU). Her work focuses on cell therapy, extracellular vesicles, and gene editing applications in regenerative medicine.

Research Interests

Raninger’s research explores:

• Extracellular vesicle functionality in inflammation and tissue regeneration
• Gene editing techniques for treating genetic skin disorders like junctional epidermolysis bullosa
• Stem cell propagation and batch effect analysis
• Immunomodulation and angiogenesis in biomedical contexts

Publication Trends

Her recent work spans molecular diagnostics (2023), stromal cell-derived EVs (2024), and extensive studies on bone marrow stromal cells (2022). Key themes include regenerative medicine, cell-based therapies, and genetic engineering.

Collaborations

Raninger collaborates with teams led by senior researchers such as Dirk Strunk and Katrin Schallmoser, contributing to projects in tissue engineering and disease-specific therapeutic development.